GlobeNewswire Inc.··Xortx Therapeutics Inc.XORTX Wins ISS Backing for Share Consolidation Plan Ahead of March Vote
XORTX Therapeutics secures ISS endorsement for share consolidation, with proxy advisor backing March 2026 shareholder vote. ISS cited no direct shareholder value impact while noting improved financing prospects.
XRTXkidney diseaseshare consolidation